|

Dapagliflozin 10 mg/Pioglitazone 30 mg/Metformin HCl 1000 mg Clinical Trials

2 actively recruiting trials

Also known as: BR3006

Pipeline

Phase 1: 2

Top Sponsors

  • Boryung Pharmaceutical Co., Ltd2

Indications

  • Diabetes2
  • Diabete Mellitus1
  • Diabetes Mellitus1

Other2 trials

A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fasting)
Phase 1
A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.